Mark Booth
Chief Executive Officer at NetJets Europe Ltd.
Mark Booth active positions
| Companies | Position | Start | End |
|---|---|---|---|
NetJets Europe Ltd.
 NetJets Europe Ltd. AirlinesTransportation Part of Berkshire Hathaway, Inc., NetJets Europe Ltd. runs a fleet of aircrafts. The company is based in Rotkreuz, Switzerland. The CEO of the Swiss company is Mark Booth. | Chief Executive Officer | - | - |
| Chairman | - | - | |
The Michael J. Fox Foundation for Parkinson's Research
 The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | Director/Board Member | 31/12/2010 | - |
Career history of Mark Booth
Statistics
International
| Switzerland | 2 |
| United States | 2 |
Operational
| Chief Executive Officer | 1 |
| Chairman | 1 |
| Director/Board Member | 1 |
Sectoral
| Transportation | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
NetJets Europe Ltd.
NetJets Europe Ltd. AirlinesTransportation Part of Berkshire Hathaway, Inc., NetJets Europe Ltd. runs a fleet of aircrafts. The company is based in Rotkreuz, Switzerland. The CEO of the Swiss company is Mark Booth. | Transportation |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Mark Booth
- Experience
